Squamous cell carcinoma of the oral cavity is a serious disease that affects the tissues inside the mouth and can significantly impact a person’s quality of life. Treatment aims to remove or destroy the cancer, prevent it from spreading, and maintain or restore the ability to eat, speak, and swallow. The approach depends on the location and size of the tumor, the stage of the disease, and each patient’s overall health. Alongside well-established surgical and radiation treatments, research is exploring new therapies that may offer additional options in the future.

Understanding Treatment Goals and the Journey Ahead

When someone receives a diagnosis of squamous cell carcinoma of the oral cavity, the path forward can feel overwhelming. This type of cancer, which makes up more than 90% of all oral malignancies, starts in the flat cells lining the lips and the inside of the mouth—cells known as squamous cells. The disease can appear on the tongue, gums, floor of the mouth, cheeks, or lips, and it may cause persistent sores, white or red patches, pain, or difficulty swallowing and speaking.^[1][2]

Treatment is not one-size-fits-all. The goal is to control the disease, preserve as much normal function as possible, and improve quality of life. For some, this means surgery to remove the tumor. For others, radiation therapy or a combination of treatments may be recommended. The choices made often depend on how early the cancer was found, where exactly in the mouth it is located, and whether it has spread to nearby lymph nodes or other parts of the body.^[1][10]

Treatment decisions are typically made by a team of specialists, including surgeons, oncologists, radiation experts, and dentists who work together to design a plan tailored to each patient. This multidisciplinary approach is crucial because oral cancer can affect many critical functions, such as eating, speaking, and breathing. The team also considers the patient’s overall health, personal preferences, and the potential side effects of each treatment option.^[2][11]

In addition to standard treatments that have been used successfully for many years, there is ongoing research into new therapies. Clinical trials are testing innovative drugs and methods that may one day become part of routine care. Understanding both the established approaches and the newer possibilities can help patients and their families make informed decisions and feel more confident about the road ahead.

Standard Treatment Approaches for Oral Cavity Cancer

The foundation of treatment for squamous cell carcinoma of the oral cavity is built on two main pillars: surgery and radiation therapy. These methods have been refined over many years and are recommended by clinical guidelines from major medical societies around the world. The choice between them, or the decision to combine both, depends on the specific characteristics of the cancer and the patient.^[1][10]

Surgery: The Primary Treatment for Many Patients

Surgery plays a central role in treating most oral cavity cancers. The goal is to remove the tumor completely, along with a margin of healthy tissue around it to ensure no cancer cells are left behind. For early-stage cancers—those that are smaller than 4 centimeters and have not invaded deeply—surgery alone may be sufficient. The surgeon aims to cut around the tumor with a border of about 1.0 to 1.5 centimeters of normal tissue in all directions, including depth.^[14][15]

The operation can be straightforward for small lesions, but it becomes more complex when the cancer is larger or located in areas that affect important structures. For example, tumors on the tongue, the floor of the mouth, or the gums may require removal of part of the jawbone (mandible) or reconstruction of soft tissues to maintain the ability to swallow and speak. Sometimes, nearby lymph nodes in the neck are also removed in a procedure called a neck dissection, especially if there is concern the cancer may have spread.^[10][14]

Advanced-stage cancers—those larger than 4 centimeters, invading deeply, or involving nearby structures—require more extensive surgery. In some cases, the disease may involve the skull base or major blood vessels, making the tumor unresectable, meaning it cannot be safely removed. In these situations, surgery is not recommended, and other treatment options are explored.^[14]

After surgery, patients may need reconstructive procedures to restore appearance and function. This can involve moving tissue from other parts of the body to rebuild the mouth, tongue, or jaw. Dental rehabilitation, including dentures or implants, may also be necessary to help with eating and speaking.^[5]

Radiation Therapy: Targeting Cancer Cells with High-Energy Beams

Radiation therapy uses high-energy rays, similar to X-rays, to kill cancer cells or stop them from growing. It is often used after surgery to destroy any remaining cancer cells and reduce the risk of the cancer coming back. This is called adjuvant radiation therapy. For some patients, especially those who cannot undergo surgery due to health reasons or tumor location, radiation may be the primary treatment.^[1][11]

Radiation is usually delivered over several weeks, with daily sessions lasting just a few minutes each. The total dose is split into smaller doses to minimize damage to healthy tissues. The treatment is carefully planned using imaging to precisely target the tumor and spare as much normal tissue as possible. Despite this precision, side effects can occur. Common side effects include soreness and redness of the mouth and throat, difficulty swallowing, dry mouth due to damage to salivary glands, changes in taste, and fatigue.^[11][21]

For advanced cancers, radiation is often combined with chemotherapy in an approach called chemoradiation. Chemotherapy involves drugs that travel through the bloodstream to kill cancer cells throughout the body. When given together with radiation, chemotherapy can make the radiation more effective. Common chemotherapy drugs used in this setting include cisplatin and carboplatin. However, combining these treatments increases side effects, such as nausea, vomiting, fatigue, and a higher risk of infections due to a drop in white blood cell counts.^[11][13]

Targeted Therapy and Immunotherapy in Standard Care

In addition to surgery, radiation, and traditional chemotherapy, some patients may receive targeted therapy or immunotherapy as part of their standard treatment, especially if the cancer is advanced or has come back after initial treatment. Targeted therapies are drugs that attack specific molecules involved in cancer growth. For example, cetuximab is a targeted drug that blocks a protein on the surface of cancer cells called the epidermal growth factor receptor (EGFR), which helps the cells grow and divide. Blocking this receptor can slow down or stop the cancer’s growth.^[13]

Immunotherapy works by helping the body’s own immune system recognize and attack cancer cells. One example is pembrolizumab, which blocks a protein called PD-1 that cancer cells use to hide from the immune system. By blocking PD-1, the immune system can “see” and destroy the cancer. These therapies are typically used for metastatic disease—cancer that has spread to distant parts of the body—or for recurrent cancers that did not respond to other treatments.^[13]

Duration of Treatment and Managing Side Effects

The length of treatment varies widely. Surgery might be completed in a single day, but recovery and rehabilitation can take weeks to months. Radiation therapy typically runs for five to seven weeks, with daily sessions Monday through Friday. Chemotherapy cycles depend on the specific drugs used and the treatment plan, often spanning several months.^[11]

Managing side effects is a critical part of care. Patients may need nutritional support, including feeding tubes if swallowing becomes too painful. Pain management, treatment for dry mouth, and speech and swallowing therapy are common supportive measures. Close follow-up with the medical team helps address complications early and maintain quality of life during and after treatment.^[11][20]

Exploring New Frontiers: Treatment in Clinical Trials

While standard treatments have saved many lives, researchers are constantly working to find better, safer, and more effective therapies. Clinical trials are carefully controlled studies that test new drugs, new combinations of existing treatments, or entirely new approaches. Participating in a clinical trial can give patients access to cutting-edge treatments that are not yet widely available, and it also contributes to scientific knowledge that may help future patients.^[4]

What Are Clinical Trials and Why Are They Important?

Clinical trials are conducted in phases, each designed to answer specific questions. Phase I trials focus on safety, testing a new treatment in a small group of people to determine the right dose and identify side effects. Phase II trials assess whether the treatment works against the cancer and continue to monitor safety in a larger group. Phase III trials compare the new treatment to the current standard treatment to see if it is better, equally effective, or has fewer side effects. Only after a treatment successfully passes through all these phases can it be approved for general use.^[4]

For oral cavity squamous cell carcinoma, clinical trials are testing a wide range of innovative approaches. These include new drugs that target specific genetic changes in cancer cells, therapies that boost the immune system, and combinations of treatments that may work better together than alone.

Targeted Molecular Therapies

Scientists are identifying specific genetic mutations and molecular pathways that drive the growth of oral cavity cancers. By understanding these mechanisms, they can develop drugs that precisely attack those abnormalities. For example, some trials are investigating tyrosine kinase inhibitors, which block enzymes that help cancer cells grow and spread. Other studies are looking at drugs that target alterations in genes such as PIK3CA or TP53, which are commonly mutated in oral cancers.^[4]

These targeted therapies aim to be more selective than traditional chemotherapy, ideally causing fewer side effects because they spare normal cells. However, they are still being tested to determine their effectiveness and safety in oral cavity cancer patients specifically.

Immunotherapy Advances

Immunotherapy has been a major focus of cancer research in recent years. Several new immunotherapy drugs are being tested in clinical trials for oral cavity cancer. These drugs work in different ways to unleash the immune system’s ability to fight cancer. In addition to PD-1 inhibitors like pembrolizumab, trials are exploring drugs that target other immune checkpoints, such as PD-L1 and CTLA-4.^[13]

Combination immunotherapy—using two or more immune-boosting drugs together—is also being investigated. The hope is that combining different mechanisms will lead to stronger and longer-lasting responses. Some trials are testing immunotherapy combined with chemotherapy or radiation to see if the combination is more effective than any single treatment alone.

Novel Drug Combinations and Mechanisms

Researchers are also studying new ways to deliver existing drugs or new combinations of drugs that may overcome resistance to treatment. For example, some clinical trials are testing drugs that inhibit angiogenesis, the process by which tumors develop new blood vessels to supply themselves with nutrients. By cutting off the tumor’s blood supply, these drugs aim to starve the cancer.^[4]

Other trials are looking at drugs that interfere with the cancer cell’s ability to repair its DNA or that make cancer cells more sensitive to radiation or chemotherapy. These approaches are based on the idea that attacking cancer from multiple angles at once may be more effective than relying on a single treatment.

Gene Therapy and Personalized Medicine

Gene therapy is an experimental approach that involves altering the genetic material inside cancer cells or immune cells to treat disease. While still in early stages for oral cavity cancer, some trials are exploring the use of viruses to deliver genes that can kill cancer cells or make them easier for the immune system to recognize.^[4]

Personalized medicine, also called precision medicine, tailors treatment to the individual characteristics of each patient’s cancer. This might involve testing the tumor for specific genetic mutations and then selecting a therapy that targets those mutations. Clinical trials are working to identify which patients are most likely to benefit from which treatments, moving away from a one-size-fits-all approach.

Where Are These Trials Conducted and Who Can Participate?

Clinical trials for oral cavity squamous cell carcinoma are being conducted in many countries, including the United States, Europe, and other parts of the world. Major cancer centers and hospitals often participate in these studies. Eligibility for a trial depends on many factors, including the stage of the cancer, prior treatments received, overall health, and specific characteristics of the tumor.^[4]

Patients interested in clinical trials should talk with their oncology team. The team can help determine if there are appropriate trials available and whether the patient meets the criteria to participate. Participation is always voluntary, and patients can withdraw from a trial at any time. It’s important to fully understand the potential risks and benefits before enrolling.

Most common treatment methods

• Surgery
  • Removal of the tumor with surrounding healthy tissue margins, typically 1.0 to 1.5 centimeters
  • Neck dissection to remove lymph nodes if cancer has spread or is at high risk of spreading
  • Reconstructive surgery to restore appearance and function after tumor removal
  • Often the first-line treatment for early-stage oral cavity cancers
• Radiation Therapy
  • High-energy beams used to kill cancer cells or stop their growth
  • Often used after surgery (adjuvant therapy) to destroy remaining cancer cells
  • Can be the primary treatment for patients unable to undergo surgery
  • Typically delivered over five to seven weeks in daily sessions
  • May be combined with chemotherapy (chemoradiation) for advanced cancers
• Chemotherapy
  • Drugs such as cisplatin and carboplatin that kill cancer cells throughout the body
  • Often combined with radiation therapy to enhance effectiveness
  • Used for advanced or metastatic disease
  • Treatment cycles span several months depending on the regimen
• Targeted Therapy
  • Drugs like cetuximab that target specific proteins on cancer cells, such as EGFR
  • Block signals that help cancer cells grow and divide
  • Typically used for advanced or recurrent cancers
  • Aim to be more selective than traditional chemotherapy
• Immunotherapy
  • Drugs like pembrolizumab that help the immune system recognize and attack cancer
  • Block proteins such as PD-1 that cancer cells use to hide from the immune system
  • Used for metastatic or recurrent cancers that have not responded to other treatments
  • Being tested in clinical trials in combination with other therapies